Could 'space bacteria' help create vaccines?

The weightless microgravity environment of space can alter disease-causing bacteria as they grow--and that's not necessarily a bad thing, CNN reports. Scientists hope understanding these changes can provide an opportunity for vaccine development. "Vaccines are about identifying targets, and in microgravity, the bacteria have unmasked themselves and revealed secrets to help develop therapeutics," Cheryl Nickerson, part of a team from Arizona State University that collaborates with NASA, told the news outlet. More

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

Behind the under-pressure blockbuster Prevnar 13 are several pipeline vaccines Pfizer hopes will propel future growth.